# BioMarin Pharmaceutical, Inc. – FDA Inspection, Dec 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/294a4562-e09d-41ef-b5da-6e26860ddf6d
Source feed: FDA_Inspections

> FDA inspection 1041169 of BioMarin Pharmaceutical, Inc., December 14, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1041169
- Company Name: BioMarin Pharmaceutical, Inc.
- Inspection Date: 2017-12-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1268309 - 2025-03-26](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/82d2a0af-f568-4ba0-b631-24e73e69b55a)
- [FDA Inspection 1251795 - 2024-08-19](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/e8b2b049-ebee-414e-99e1-b3ba421792a2)
- FDA Inspection 1076844 - 2018-11-09
- FDA Inspection 991276 - 2016-11-04
- FDA Inspection 878935 - 2014-04-17

## Related Officers

- [Ashar P. Parikh](https://www.keypedia.com/people/ashar-p-parikh/f5430c51-31c7-44bb-90f7-1ec8ae581343)
- [FDA Associated Person](https://www.keypedia.com/people/jolanna-a-norton/5501fea4-4bfd-434c-b2aa-fcf94444f684)
- [Company Rep](https://www.keypedia.com/people/joslyn-k-brunelle/455a0e51-af2c-4a24-aacd-d455fda96eba)
- Issuing Officer

Company: https://www.keypedia.com/companies/biomarin-pharmaceutical-inc/7811b401-4321-4df1-b9b5-deef8905c101

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
